Table 4.
HRQoL of lymphoma patients during the pandemic and pre-pandemic
| HRQoL scale/item | HRQoL of patients, mean (SD) | P value | |
|---|---|---|---|
| In the pandemic (n = 1106) | In 2019 pre-pandemic (n = 1106) | ||
| Global health status/QoL | 70.1 (21.4) | 59.7 (23.1) | < 0.001* |
| Functional scale | |||
| Physical functioning | 81.9 (16.5) | 79.2 (18.1) | 0.025* |
| Role functioning | 81.3 (24.1) | 73.7 (27.3) | < 0.001* |
| Emotional functioning | 74.9 (21.0) | 66.0 (23.7) | < 0.001* |
| Cognitive functioning | 78.4 (19.6) | 74.4 (21.2) | < 0.001* |
| Social functioning | 62.3 (28.6) | 49.3 (30.1) | < 0.001* |
| Symptom scale/item | |||
| Fatigue | 35.9 (22.1) | 41.6 (22.7) | 0.81 |
| Nausea and vomiting | 9.1 (17.2) | 10.7 (18.9) | 0.019* |
| Pain | 18.7 (21.2) | 20.3 (21.5) | 0.12 |
| Dyspnea | 17.1 (21.2) | 22.3 (23.7) | 0.006* |
| Insomnia | 28.6 (29.0) | 31.6 (28.5) | < 0.001* |
| Appetite loss | 16.2 (23.3) | 21.2 (24.6) | 0.89 |
| Constipation | 15.1 (5.22) | 16.4 (24.6) | < 0.001* |
| Diarrhea | 11.9 (19.3) | 13.8 (20.5) | 0.072 |
| Financial difficulties | 46.3 (34.6) | 62.2 (34.4) | < 0.001* |
*P < 0.05